News from Replimune Group Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 14, 2017, 07:33 ET Replimune Announces First Patients Dosed in a Phase 1/2 Clinical Trial of its RP1 Oncolytic Immunotherapy in Patients With Advanced Solid Tumors

Replimune Group Inc., a biotechnology company developing next generation oncolytic immunotherapies, announced today that the first cohort of...


Sep 08, 2017, 05:00 ET Replimune Appoints Howard L. Kaufman, M.D., FACS as Chief Medical Officer

Replimune Group Inc. announced today a key addition to its senior leadership team as it progresses its Immulytic™ oncolytic immunotherapy platform...


Sep 08, 2017, 05:00 ET Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs

Replimune Group Inc., a biotechnology company focused on developing next generation oncolytic immunotherapies, announced today the completion of a...